NCT04380337 2025-02-25
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer
Stanford University
Phase 2 Completed
Clinical Trials
14 trialsNCT06242418 2024-12-12
REVISE
West China Hospital
Phase 2 Recruiting
NCT06575127 2024-08-28
Modified FOLFOXIRI Plus Target Therapy as a First Line Treatment for Advanced Colorectal Cancer a Prospective Phase Two Study
Al-Azhar University
Phase 2 Recruiting
NCT01328171 2023-06-15
VOLFI
AIO-Studien-gGmbH
Phase 2 Completed
NCT05316818 2022-04-07
Triplet (FOLFOXIRI) vs. Doublet (FOLFOX or FOLFIRI) Regimen as a 1st Line Treatment in Metastatic Colorectal Carcinoma
Kasr El Aini Hospital
Phase 2 Completed
NCT03484195 2021-04-19
Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer
China Medical University, China
Phase 2 Unknown
NCT03487939 2021-04-19
Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer
China Medical University, China
Phase 2 Unknown
NCT02217020 2021-04-14
FORTUNE
Sun Yat-sen University
Phase 2 Completed
NCT03484221 2021-04-14
Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer
China Medical University, China
Phase 2 Unknown
NCT04838496 2021-04-09
MEND-IT
Catharina Ziekenhuis Eindhoven
Phase 2 Not yet recruiting
NCT04832776 2021-04-06
FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases
Fudan University
Phase 2 Unknown
NCT02942563 2018-01-03
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
RenJi Hospital
Phase 2 Unknown
NCT02350530 2016-09-20
FORBES
Sun Yat-sen University
Phase 2 Unknown
NCT02128425 2014-05-07
FOLFOXIRI Compared to FOLFOX in First Line Treatment of Metastatic Colorectal Cancer
Sun Yat-sen University
Phase 2 Unknown